Combination drug

Results: 675



#Item
201WHOPAR [FDA] Aurobindo Abacavir 300 mg tabs

WHOPAR [FDA] Aurobindo Abacavir 300 mg tabs

Add to Reading List

Source URL: apps.who.int

Language: English - Date: 2009-10-16 03:51:10
202FDA Tentative Approval November 8, 2005 Lamivudine Oral Solution (10 mg/mL) Aurobindo Pharma, Ltd. 1

FDA Tentative Approval November 8, 2005 Lamivudine Oral Solution (10 mg/mL) Aurobindo Pharma, Ltd. 1

Add to Reading List

Source URL: apps.who.int

Language: English - Date: 2009-12-08 04:25:30
203This list contains the drug products available through Navitus SpecialtyRx Program

This list contains the drug products available through Navitus SpecialtyRx Program

Add to Reading List

Source URL: www.deancare.com

Language: English - Date: 2013-12-26 16:12:00
204Achillion Reports 100% SVR12 in a Phase 2 Combination Study With ACH-3102 at the Liver Meeting[removed]AASLD) - Achillion Achieves 100% SVR12 in Eight-Week Phase 2 Trial Evaluating a Ribavirin-Free Regimen of ACH-3102 and

Achillion Reports 100% SVR12 in a Phase 2 Combination Study With ACH-3102 at the Liver Meeting[removed]AASLD) - Achillion Achieves 100% SVR12 in Eight-Week Phase 2 Trial Evaluating a Ribavirin-Free Regimen of ACH-3102 and

Add to Reading List

Source URL: www.hepcassoc.org

Language: English - Date: 2014-11-10 11:48:35
205Popular HCV Drug Combo Wins FDA Backing Nov 6, 2014 By Michael Smith, North American Correspondent, MedPage Today A drug combination widely used off-label to treat hepatitis C (HCV) has been given the nod by the FDA. The

Popular HCV Drug Combo Wins FDA Backing Nov 6, 2014 By Michael Smith, North American Correspondent, MedPage Today A drug combination widely used off-label to treat hepatitis C (HCV) has been given the nod by the FDA. The

Add to Reading List

Source URL: www.hepcassoc.org

Language: English - Date: 2014-11-07 08:54:14
206New drug could eliminate hepatitis C in 15 years The Pharmaceutical Journal, 10 SEP 2014, By Janna Lawrence Daclatasvir is estimated to cure chronic hepatitis C infection in up to 99% of cases when used in combination wi

New drug could eliminate hepatitis C in 15 years The Pharmaceutical Journal, 10 SEP 2014, By Janna Lawrence Daclatasvir is estimated to cure chronic hepatitis C infection in up to 99% of cases when used in combination wi

Add to Reading List

Source URL: www.hepcassoc.org

Language: English - Date: 2014-09-15 11:42:23
207Bristol-Myers pulls U.S. marketing application for hepatitis C treatment Oct 7 (Reuters) - Bristol-Myers Squibb said it withdrew its U.S. marketing application for a drug combination to treat hepatitis C. The drugmaker w

Bristol-Myers pulls U.S. marketing application for hepatitis C treatment Oct 7 (Reuters) - Bristol-Myers Squibb said it withdrew its U.S. marketing application for a drug combination to treat hepatitis C. The drugmaker w

Add to Reading List

Source URL: www.hepcassoc.org

Language: English - Date: 2014-10-08 16:23:27
208FOURTH INVITATION FOR EXPRESSION OF INTEREST (EOI) (Artemisinin based Antimalarial Products) May 2005 In the context of facilitating access to Artemisinin based combination antimalarial drug products, Roll Back Malaria (

FOURTH INVITATION FOR EXPRESSION OF INTEREST (EOI) (Artemisinin based Antimalarial Products) May 2005 In the context of facilitating access to Artemisinin based combination antimalarial drug products, Roll Back Malaria (

Add to Reading List

Source URL: apps.who.int

Language: English - Date: 2007-07-04 05:34:04
209HIV/AIDS Expression of Interest EOI

HIV/AIDS Expression of Interest EOI

Add to Reading List

Source URL: apps.who.int

Language: English - Date: 2008-05-28 07:41:36
210Kansas State Group Health Insurance Program Member Preferred Drug List 2015

Kansas State Group Health Insurance Program Member Preferred Drug List 2015

Add to Reading List

Source URL: www.kdheks.gov

Language: English - Date: 2014-12-05 08:16:34